Veterinary Medicines

Canigen DH(A2)PPi/L vakcina A.U.V.

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
  • Canine parainfluenza virus, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle VR128, Live
Download as PDF

Product identification

Medicine name:
Canigen DH(A2)PPi/L vakcina A.U.V.
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
  • Canine parainfluenza virus, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle VR128, Live
Target species:
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    800.00
    million cells
    /
    1.00
    unit(s)/dose
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
    800.00
    million cells
    /
    1.00
    unit(s)/dose
  • Canine parainfluenza virus, strain Manhattan, Live
    5.00
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine parvovirus, strain Cornell 780916, Live
    5.00
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine adenovirus 2, strain Manhattan, Live
    300.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Canine distemper virus, strain Lederle VR128, Live
    3.00
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: